DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Leroy V, Angus P, Bronowicki JP et al.
Daclatasvir, Sofosbuvir, and Ribavirin for Hepatitis C Virus Genotype 3 and Advanced Liver Disease: A Randomized Phase III Study (ALLY-3+).
Hepatology 2016;
DOI: 10.1002/hep.28473.
We do not assume any responsibility for the contents of the web pages of other providers.